New consumer and digital health technologies have proliferated, covering a wide variety of disorders such as depression, anxiety, eating disorders, and even addictions. However, the quality of these apps is variable, as little to no regulation exists. Consumer apps and devices do not have the same robust efficacy and safety studies as FDA-approved treatments. Despite this, clinicians have an opportunity to incorporate these connected health technologies into their practice and prepare for future consumer technologies. Dr. Chan will discuss how to critically evaluate tools for use and implementation in clinical practice.